| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $244.7M | +19.3% |
| Cost of Revenue | $210.0M | +25.1% |
| Gross Profit | $34.7M | -11.9% |
| R&D Expense | $40.1M | +27.6% |
| SG&A Expense | $233.8M | +11.3% |
| Operating Income | -$471.4M | -114.3% |
| Pre-tax Income | -$356.7M | -81.9% |
| Income Tax | $2.0M | +861.7% |
| Net Income | -$358.7M | -82.7% |
| EPS (Basic) | -$1.29 | +48.6% |
| EPS (Diluted) | -$1.29 | +48.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.5M | -74.0% |
| Accounts Receivable | $2.2M | -73.9% |
| Inventory | $1.5M | -94.6% |
| Current Assets | $64.8M | -71.7% |
| Total Assets | $225.7M | -62.2% |
| Current Liabilities | $134.6M | +0.5% |
| Total Liabilities | $200.5M | -27.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.8M | +56.8% |
| Capital Expenditures | $527K | -37.7% |
| Investing Cash Flow | -$89.4M | +58.5% |
| Financing Cash Flow | $19.6M | -95.6% |
| Free Cash Flow | -$57.4M | +56.7% |
| Stockholders' Equity |
| $25.1M |
| -92.2% |